Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 3 | 1 | — | — | — | 3 |
Head and neck neoplasms | D006258 | — | — | 1 | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Drug common name | INUPADENANT |
INN | inupadenant |
Description | Inupadenant is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | adenosine receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[S@+]([O-])CCOc1cc(N2CCN(CCn3c(=O)sc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)cc1F |
PDB | — |
CAS-ID | 2246607-08-7 |
RxCUI | — |
ChEMBL ID | CHEMBL4650331 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | HQ700V0X06 (ChemIDplus, GSRS) |